Abner Herrman & Brock LLC Abbott Laboratories Transaction History

Abner Herrman & Brock LLC

$829 Million
Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 140,724 shares of ABT stock, worth $16.2 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

140,724

Previous 141,135 0.29%

Holding current value

$16.2 Million

Previous $14.7 Million 9.4%

% of portfolio

1.94%

Previous 1.86%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$100.07 - $118.13 $41,128 - $48,551	-411 Reduced 0.29%	140,724 $16 Million
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $279,022 - $311,458	-2,770 Reduced 1.92%	141,135 $14.7 Million
Q1 2024 Apr 09, 2024	SELL	$109.52 - $120.96 $329,983 - $364,452	-3,013 Reduced 2.05%	143,905 $16.4 Million
Q4 2023 Jan 09, 2024	SELL	$90.19 - $110.4 $298,168 - $364,982	-3,306 Reduced 2.2%	146,918 $16.2 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $67,157 - $80,577	-703 Reduced 0.47%	150,224 $14.5 Million
Q2 2023 Jul 05, 2023	SELL	$100.78 - $112.29 $2.43 Million - $2.71 Million	-24,121 Reduced 13.78%	150,927 $16.5 Million
Q1 2023 Apr 13, 2023	BUY	$96.86 - $114.01 $189,070 - $222,547	1,952 Added 1.13%	175,048 $17.7 Million
Q4 2022 Jan 04, 2023	BUY	$95.06 - $111.52 $52,663 - $61,782	554 Added 0.32%	173,096 $19 Million
Q3 2022 Oct 06, 2022	SELL	$96.76 - $112.03 $79,343 - $91,864	-820 Reduced 0.47%	172,542 $16.7 Million
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $850,345 - $1.03 Million	-8,331 Reduced 4.59%	173,362 $18.8 Million
Q1 2022 Apr 07, 2022	SELL	$114.02 - $139.04 $30,101 - $36,706	-264 Reduced 0.15%	181,693 $21.5 Million
Q4 2021 Jan 13, 2022	SELL	$115.53 - $141.46 $45,056 - $55,169	-390 Reduced 0.21%	181,957 $25.6 Million
Q3 2021 Oct 06, 2021	SELL	$116.66 - $129.06 $696,110 - $770,101	-5,967 Reduced 3.17%	182,347 $21.5 Million
Q2 2021 Jul 09, 2021	SELL	$105.79 - $124.53 $587,769 - $691,888	-5,556 Reduced 2.87%	188,314 $21.8 Million
Q1 2021 Apr 09, 2021	SELL	$108.84 - $128.23 $1.4 Million - $1.65 Million	-12,852 Reduced 6.22%	193,870 $23.2 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $679,350 - $740,297	-6,470 Reduced 3.03%	206,722 $22.6 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $640,105 - $777,360	-6,985 Reduced 3.17%	213,192 $23.2 Million
Q2 2020 Jul 10, 2020	SELL	$76.57 - $98.0 $761,565 - $974,708	-9,946 Reduced 4.32%	220,177 $20.1 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $1.38 Million - $2.02 Million	-21,968 Reduced 8.71%	230,123 $18.2 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $1.95 Million - $2.17 Million	-24,850 Reduced 8.97%	252,091 $21.9 Million
Q3 2019 Oct 11, 2019	SELL	$81.84 - $88.74 $328,505 - $356,202	-4,014 Reduced 1.43%	276,941 $23.2 Million
Q2 2019 Jul 19, 2019	BUY	$72.88 - $85.0 $252,383 - $294,355	3,463 Added 1.25%	280,955 $23.6 Million
Q1 2019 Apr 08, 2019	BUY	$66.22 - $80.06 $3.15 Million - $3.81 Million	47,596 Added 20.7%	277,492 $22.2 Million
Q4 2018 Jan 11, 2019	BUY	$65.56 - $74.27 $441,743 - $500,431	6,738 Added 3.02%	229,896 $16.6 Million
Q3 2018 Oct 19, 2018	BUY	$60.81 - $73.36 $467,081 - $563,478	7,681 Added 3.56%	223,158 $16.4 Million
Q2 2018 Jul 06, 2018	BUY	$57.57 - $63.54 $220,665 - $243,548	3,833 Added 1.81%	215,477 $13.1 Million
Q1 2018 Apr 06, 2018	BUY	$56.27 - $63.62 $298,343 - $337,313	5,302 Added 2.57%	211,644 $12.7 Million
Q4 2017 Jan 05, 2018	BUY	$53.68 - $57.47 $257,288 - $275,453	4,793 Added 2.38%	206,342 $11.8 Million
Q3 2017 Oct 06, 2017	BUY	$48.06 - $53.64 $9.69 Million - $10.8 Million	201,549	201,549 $10.8 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Account

Abner Herrman & Brock LLC Abbott Laboratories Transaction History